UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Bromide levels in natural waters: its relationship to levels of both chloride and total dissolved solids and the implications for water treatment

Chemosphere (Oxford), 2004-10, Vol.57 (4), p.329-335

2004

Volltextzugriff (PDF)

Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors

Journal of medicinal chemistry, 2007-03, Vol.50 (6), p.1146-1157

2007

Volltextzugriff (PDF)

Preparation, Characterization, and the Crystal Structure of the Inhibitor ZK-807834 (CI-1031) Complexed with Factor Xa

Biochemistry (Easton), 2000-10, Vol.39 (41), p.12534-12542

2000

Volltextzugriff (PDF)

Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial

The Journal of infectious diseases, 2024-07

2024

Volltextzugriff (PDF)

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

Nature microbiology, 2022-11, Vol.7 (11), p.1906-1917

2022

Volltextzugriff (PDF)

Safety and Efficacy of SAB-185 for Non-hospitalized Adults with COVID-19: A Randomized Clinical Trial

The Journal of infectious diseases, 2024-07

2024

Volltextzugriff (PDF)

Design, Synthesis, and Activity of 2,6-Diphenoxypyridine-Derived Factor Xa Inhibitors

Journal of medicinal chemistry, 1999-05, Vol.42 (10), p.1749-1756

1999

Volltextzugriff (PDF)

Arsenic speciation and toxicity in biological systems

Reviews of environmental contamination and toxicology, 2005, Vol.184, p.97-149

2005

Volltextzugriff (PDF)

Design, Synthesis, and Activity of a Novel Series of Factor Xa Inhibitors: Optimization of Arylamidine Groups

Journal of medicinal chemistry, 2002-06, Vol.45 (12), p.2484-2493

2002

Volltextzugriff (PDF)

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trialResearch in context

EClinicalMedicine, 2024-09, Vol.75, p.102787

2024

Volltextzugriff (PDF)

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

EClinicalMedicine, 2023-11, Vol.65, p.102250, Article 102250

2023

Volltextzugriff (PDF)

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trialResearch in context

EClinicalMedicine, 2023-11, Vol.65, p.102250

2023

Volltextzugriff (PDF)

Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogs

Journal of medicinal chemistry, 1991-09, Vol.34 (9), p.2671-2677

1991

Volltextzugriff (PDF)

Cardiotonic agents. 1. Novel 8-aryl substituted imidazo[1,2-a]- and -[1,5-a]pyridines and imidazo[1,5-a]pyridinones as potential positive inotropic agents

Journal of medicinal chemistry, 1987-08, Vol.30 (8), p.1337-1342

1987

Volltextzugriff (PDF)

Novel 3-Oxa Lipoxin A4 Analogues with Enhanced Chemical and Metabolic Stability Have Anti-inflammatory Activity in Vivo

Journal of medicinal chemistry, 2004-04, Vol.47 (8), p.2157-2165

2004

Volltextzugriff (PDF)

REINTEGRATION OF CROP-LIVESTOCK SYSTEMS IN EUROPE: AN OVERVIEW

Frontiers of Agricultural Science and Engineering, 2021-01, Vol.8 (1), p.111-129

2021

Volltextzugriff (PDF)

Allosteric Inhibitors of Inducible Nitric Oxide Synthase Dimerization Discovered via Combinatorial Chemistry

Proceedings of the National Academy of Sciences - PNAS, 2000-02, Vol.97 (4), p.1506-1511

2000

Volltextzugriff (PDF)

Synthesis of 6-phenylimidazo[1,2-a]pyrazin-8-one and 1-methyl-6-phenylimidazo[1,5-a]pyrazin-8-one via quaternary intermediates

Journal of organic chemistry, 1987-09, Vol.52 (19), p.4379-4381

Davey, David D

1987

Volltextzugriff (PDF)

A Neural Network Approach to Zinc and Copper Interferences in Potentiometric Stripping Analysis

Journal of intelligent material systems and structures, 1997-02, Vol.8 (2), p.177-183

1997

Volltextzugriff (PDF)

Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase

Bioorganic & medicinal chemistry letters, 2008-07, Vol.18 (14), p.3891-3894

2008

Volltextzugriff (PDF)

Synthesis of novel 8-arylimidazo[1,2-a]pryidines and 8-arylimidazo[1,5-a]pyridines

Journal of organic chemistry, 1987-05, Vol.52 (9), p.1863-1867

Davey, David D

1987

Volltextzugriff (PDF)

Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agents

Journal of medicinal chemistry, 1987-05, Vol.30 (5), p.755-758

1987

Volltextzugriff (PDF)

Synthesis of novel (aryloxy)propanolamines and related compounds possessing both class II and class III antiarrhythmic activity

Journal of medicinal chemistry, 1990-10, Vol.33 (10), p.2883-2891

1990

Volltextzugriff (PDF)

Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A sub(4) hydrolase

Bioorganic & medicinal chemistry, 2008-07, Vol.18 (14), p.3891-3894

2008

Volltextzugriff (PDF)

1 – 25 von 1.865

Suche als RSS-Feed

Aktive Filter

ThemaPhysical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.680)
Mit Volltextzugriff
(1.551)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.213)
Life Sciences & Biomedicine
(1.089)
Humans
(862)
Male
(526)
Female
(471)
Adult
(322)
Biological And Medical Sciences
(312)
Middle Aged
(295)
Medical Sciences
(238)
Aged
(201)
Risk Factors
(192)
Epidemiology
(139)
Public, Environmental & Occupational Health
(139)
Adolescent
(138)
Animals
(138)
General & Internal Medicine
(137)
Cohort Studies
(133)
Mortality
(131)
Child
(129)
Medicine, General & Internal
(127)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Bmj. British Medical Journal
(39)
International Journal Of Epidemiology
(39)
Bmj
(38)
Plos One
(35)
Soil Biology & Biochemistry
(33)
Nature Genetics
(32)
Plos Genetics
(28)
Meeting Abstracts
(24)
Nature Communications
(24)
Bmj : British Medical Journal
(23)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(10)
... seit 90 Tagen
(26)

Menü

Weitere Dienste

Einstellungen

Bromide levels in natural waters: its relationship to levels of both chloride and total dissolved solids and the implications for water treatment

Design, Synthesis, and Activity of 2-Imidazol-1-ylpyrimidine Derived Inducible Nitric Oxide Synthase Dimerization Inhibitors

Preparation, Characterization, and the Crystal Structure of the Inhibitor ZK-807834 (CI-1031) Complexed with Factor Xa

Safety and Efficacy of SAB-185 for Nonhospitalized Adults With COVID-19: A Randomized Clinical Trial

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

Safety and Efficacy of SAB-185 for Non-hospitalized Adults with COVID-19: A Randomized Clinical Trial

Design, Synthesis, and Activity of 2,6-Diphenoxypyridine-Derived Factor Xa Inhibitors

Discovery of N-[2-[5-[Amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro- 6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]-N-methylglycine (ZK-807834): A Potent, Selective, and Orally Active Inhibitor of the Blood Coagulation Enzyme Factor Xa

Arsenic speciation and toxicity in biological systems

Design, Synthesis, and Activity of a Novel Series of Factor Xa Inhibitors: Optimization of Arylamidine Groups

Post-acute COVID-19 outcomes including participant-reported long COVID: amubarvimab/romlusevimab versus placebo in the ACTIV-2 trialResearch in context

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial

Safety and efficacy of inhaled interferon-β1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trialResearch in context

Novel compounds possessing potent cAMP and cGMP phosphodiesterase inhibitory activity. Synthesis and cardiovascular effects of a series of imidazo[1,2-a]quinoxalinones and imidazo[1,5-a]quinoxalinones and their aza analogs

Cardiotonic agents. 1. Novel 8-aryl substituted imidazo[1,2-a]- and -[1,5-a]pyridines and imidazo[1,5-a]pyridinones as potential positive inotropic agents

Novel 3-Oxa Lipoxin A4 Analogues with Enhanced Chemical and Metabolic Stability Have Anti-inflammatory Activity in Vivo

REINTEGRATION OF CROP-LIVESTOCK SYSTEMS IN EUROPE: AN OVERVIEW

Allosteric Inhibitors of Inducible Nitric Oxide Synthase Dimerization Discovered via Combinatorial Chemistry

Synthesis of 6-phenylimidazo[1,2-a]pyrazin-8-one and 1-methyl-6-phenylimidazo[1,5-a]pyrazin-8-one via quaternary intermediates

A Neural Network Approach to Zinc and Copper Interferences in Potentiometric Stripping Analysis

Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A4 hydrolase

Synthesis of novel 8-arylimidazo[1,2-a]pryidines and 8-arylimidazo[1,5-a]pyridines

Rational design of 4-[(methylsulfonyl)amino]benzamides as class III antiarrhythmic agents

Synthesis of novel (aryloxy)propanolamines and related compounds possessing both class II and class III antiarrhythmic activity

Synthesis of N-alkyl glycine amides as potent inhibitors of leukotriene A sub(4) hydrolase

Aktive Filter

Suchergebnisse filtern